ELF Stock After Q1 FY2027: The 153% Beat, Explained
e.l.f. Beauty (NYSE: ELF) posted one of the largest earnings beats of the season and the stock still fell — because roughly $0.68 of the $1.75 adjusted EPS was a one-time tariff refund, and a third of revenue came from an acquired brand. Shares closed the 5 August regular session at $86.37, down 1.7%, then fell a further 2.8% in after-hours trading. This was a quarter that looked spectacular on the headline and merely solid underneath — and the underneath is what you are buying.

What did e.l.f. Beauty report for Q1 FY2027?
e.l.f. Beauty grew net sales 36% to $479.4 million and lifted its full-year outlook, with most of the margin expansion traceable to refunded tariffs. Gross margin rose approximately 1,400 basis points to 83%, including roughly 1,050 basis points of benefit from IEEPA tariff refunds, with the rest from pricing and lower year-over-year tariff rates. GAAP net income was $66.6 million ($1.12 diluted), adjusted net income was $104.6 million ($1.75 adjusted diluted), and adjusted EBITDA was $168.2 million, or 35% of net sales, up 93% year over year.
| Q1 FY2027 (3 months ended 30 Jun 2026) | Reported | Prior year | Change |
|---|---|---|---|
| Net sales | $479.4M | $353.7M | +36% |
| Gross margin | ~83% | ~69% | +~1,400bp |
| Operating income | $102.4M | $48.7M | +110% |
| GAAP diluted EPS | $1.12 | $0.58 | +93% |
| Adjusted diluted EPS | $1.75 | $0.89 | +97% |
| Adjusted EBITDA | $168.2M | $87.1M | +93% |
| Cash / total debt | $344.2M / $834.2M | $170.0M / $256.7M | debt +225% |
The adjusted figure beat the FactSet consensus of $0.72, a surprise of roughly 154% against the $0.69 estimate compiled elsewhere.
Why did ELF stock fall on a 153% earnings beat?
The stock fell because the beat was concentrated in items that do not repeat, and the market had already paid for the good news. Heading into the print, 18 analysts rated the shares a Buy with a consensus target of $82.13 — below the then-current price of $87.84 — after a roughly 40% rally since May. The shares had risen 7.1% in the week ending 31 July alone.
When a stock trades above the Street's average target into a quarter, a beat has to change the earnings base to move the price. This one largely did not — which is the subject of the next two sections.
How much of the quarter was one-time tariff money?
Roughly $0.68 of the $1.75 adjusted EPS came from tariff refunds, meaning the underlying figure was closer to $1.07. Goldman Sachs attributed a $0.68 per share benefit to tariff refunds and raised its price target to $100 from $95 while keeping a Buy rating. e.l.f. received approximately $50 million in tariff refunds plus related interest on duties struck down by the Supreme Court, and CEO Tarang Amin said the plan is to reinvest that money fully into pricing and increased marketing.
| Adjusted EPS bridge, Q1 FY2027 | $/share |
|---|---|
| Reported adjusted diluted EPS | $1.75 |
| Less: estimated tariff-refund benefit | ($0.68) |
| Implied ex-refund adjusted EPS | ~$1.07 |
| Prior-year Q1 adjusted EPS | $0.89 |
| Implied underlying growth | ~+20% |
This bridge is an estimate, not a company disclosure. It uses a broker's allocation, and a fully clean comparison would also need to adjust the prior-year quarter for the tariff costs it was carrying. Treat roughly +20% as a directional read, not a precise number. Even so, the gap matters: sales grew 36% while underlying earnings grew about 20% — operating deleverage, not leverage.
The legal backdrop is also unresolved. The Supreme Court held 6-3 on 20 February 2026 in Learning Resources, Inc. v. Trump that IEEPA does not authorise the President to impose tariffs, invalidating the reciprocal and trafficking tariffs. The administration replaced them the same day with a Section 122 global surcharge, and CBP stopped collecting IEEPA duties from 24 February 2026; the Court of International Trade then invalidated the Section 122 tariffs on 7 May 2026, though relief was limited to the three plaintiff importers and the government has appealed. The administration has been pivoting toward Section 232 and Section 301, which are considered more legally durable. For a China-sourced value cosmetics company, the input-cost regime for FY2028 is genuinely unknown.
Is the core e.l.f. brand still shrinking?
Yes — the acquired rhode brand supplied roughly a third of revenue while the rest of the business appears to have contracted by high single digits. rhode contributed about $160 million, or 33.4% of quarterly revenue; the remaining business at roughly $319.4 million implies a decline of about 9.7% year over year, a figure the company did not itself disclose. Management had guided first-quarter organic sales to decline in the high-single-digit range, attributing it to a difficult comparison created by elevated shipments ahead of last year's ERP transition.
That explanation is credible and testable — a shipment-timing comp reverses in the following quarter. But it sits alongside a slower-moving problem. Nielsen data indicated core consumption softened to a low-to-mid single-digit decline in June rolling four-week periods, and the company has been implementing selective price cuts to drive unit recovery. About 75% of items are priced at $10 or below, and the company permanently reduced prices on roughly 10% of its range after demand testing.
The bull counterpoint is distribution, not price. US net sales rose 29% and international rose 61% in the quarter, and international is only about 20% of revenue versus upwards of 70% for larger competitors, with rhode launching in 19 European countries in September.
What does the raised FY2027 guidance actually say?
The guidance raise is smaller than the quarter's beat — which is management telling you the windfall is being spent, not banked. Full-year adjusted EPS guidance went to $3.50–$3.55 from $3.27–$3.32, and net sales to $1,938–$1,968 million from $1,835–$1,865 million.
Run the arithmetic: the Q1 adjusted EPS beat alone was about $1.03 versus consensus, while the full-year raise was $0.23. The roughly $0.80 difference is an implicit reduction in expectations for the remaining three quarters. That is consistent with the stated plan: full reinvestment of the $50 million tariff refund into pricing and marketing, with marketing and digital spend guided to the high end of 23–25% of net sales, gross margin up about 200 basis points for the year, organic growth raised to 6–7%, and rhode contributing about 13 percentage points of growth.
Read charitably, that is a company converting a legal windfall into price competitiveness and share. Read sceptically, it is a company whose organic engine needs subsidising. Both readings fit the same numbers — which is precisely why the stock did not rerate.
What are you paying at roughly $86, and what breaks the thesis?
You are paying a premium multiple for an earnings base that is being deliberately suppressed this year. Goldman noted the stock trades at a P/E of about 199 and that the shares had gained 5% over the past week. On the raised adjusted EPS guidance of $3.50–$3.55, roughly $86 is about 24x forward adjusted earnings — the gap between those two multiples is the analytical question, since the adjusted figure excludes stock-based compensation, contingent-consideration marks and intangible amortisation, all of which are real and rising post-rhode. Amortisation of acquired intangibles was $11.1 million in the quarter and stock-based compensation $19.7 million.
Three observable checkpoints settle the debate, and the next one prints in early November:
Q2 organic growth. Management framed the Q1 decline as a shipment comp. If organic does not turn convincingly positive next quarter, the ERP explanation is exhausted.
Core consumption trend. Nielsen/Circana scanner data on the base e.l.f. cosmetics brand — price cuts must show up as unit growth within two quarters, or value positioning is losing to category softness.
rhode after annualisation. rhode is 33.4% of revenue today; from Q2 it enters the organic base. Its growth rate becomes the company's growth rate, and the earnout marks become an ongoing P&L item.
Balance-sheet risk deserves a line of its own: total debt rose to $834.2 million from $256.7 million a year earlier, and goodwill plus intangibles now represent roughly 57% of total assets. A growth stumble at rhode would hit revenue, the earnout liability and the impairment test simultaneously.
FAQ
Q: Did ELF beat earnings in Q1 FY2027?
Yes, by a wide margin. Adjusted EPS of $1.75 beat the $0.69 estimate by about 154%, on revenue of $479.4 million versus roughly $430 million expected. Much of the outperformance came from one-time tariff refunds rather than operations.
Q: Why did ELF stock drop after such a big beat?
Because the beat was largely non-recurring and the shares had already run. A tariff refund contributed an estimated $0.68 per share of the $1.75, and the stock was trading above the $82.13 consensus target after a roughly 40% rally since May. Shares closed down 1.7% and fell a further 2.8% after hours.
Q: How much of e.l.f. Beauty's revenue is rhode?
rhode contributed approximately $160 million in the June 2026 quarter, or 33.4% of net sales. The brand enters the organic comparison base from the second quarter of fiscal 2027, at which point its growth rate materially determines the company's reported growth.
Q: Will the tariff refunds repeat next quarter?
No. The refunds stem from the Supreme Court's February 2026 ruling invalidating IEEPA tariffs, making them a one-time recovery of duties already paid. Replacement tariffs under Section 122 took effect from 24 February 2026, and the durable tariff regime for imported cosmetics remains unsettled.
Q: Is ELF stock expensive at around $86?
It depends entirely on which earnings number you use. On trailing GAAP earnings the P/E is roughly 199; on the raised fiscal 2027 adjusted EPS guidance of $3.50–$3.55 the forward multiple is roughly 24x. The adjusted figure excludes stock compensation, intangible amortisation and rhode earnout marks.
Risk Warning: Trading financial instruments involves significant risk and may result in the loss of your invested capital. Please ensure you fully understand the risks and seek independent professional advice if necessary. This article does not constitute investment advice or a trading recommendation. Past performance is not indicative of future results.
Bonus rebate to help investors grow in the trading world!